D-0078-2018 Class III Terminated
FDA drug recall D-0078-2018 was initiated by Allergan Sales, LLC on Oct 19, 2017 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications. The recall status is terminated (terminated Oct 30, 2019). Affected quantity: 153,616 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 22, 2017
- Initiation Date
- Oct 19, 2017
- Termination Date
- Oct 30, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 153,616 bottles
Product description
Lumigan (bimatoprost ophthalmic solution) 0.01%, 2.5 mL bottle, Rx only, Allergan, Irvine, CA 92612. NDC# 0023-3205-03
Reason for recall
Failed Impurities/Degradation Specifications.
Distribution pattern
Nationwide and Barbados, Curacao, Dominican Republic, Guyana, Jamaica, and Trinidad and Tobago.
Code information
Lot #: 92575 Exp. JUN-2018
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0078-2018
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026